Bolar provisions in India's patent law


In May 2003, when India's Patent Act was amended, a new Section 107A was introduced. This provided for a research exemption as an exception to the general rules of patent infringement. Commonly known as a Bolar provision, this research exemption enables a manufacturer of generic drugs to use a patented invention to obtain marketing approval without the patent owner's permission before the patent expires. The generic drug maker...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Eminem's publishers sue New Zealand's National Party for use of song in campaign commercial: http://t.co/N9vgQ9pPq2

Sep 16 2014 05:48 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @filemot: Women in #aippi2014 refuse to be silenced for a presentation, but there are a lot of them http://t.co/psmi0imyDc

Sep 15 2014 11:23 ·  reply ·  retweet ·  favourite
ManagingIP profile

@noelcip Made from the finest Canadian impermeable paper, of course :) #AIPPI2014 #keepdry

Sep 15 2014 09:37 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPPI Congress News 2014

Read this year's AIPPI Congress News - published daily by Managing IP direct from the AIPPI Annual Meeting in Toronto null

September 2014

The surprising rise of the PTAB

Patent owners have been shocked at how popular IPR proceedings at the PTAB have proven. As the USPTO mulls over changes and the Federal Circuit braces itself for a deluge of appeals, Michael Loney reports on how the PTAB is likely to evolve



Most read articles

Supplements